Effects of Depression and Antidepressant Use on Goal Setting and Barrier Identification Among Patients With Type 2 Diabetes
Purpose The purpose of this study was to examine the effects of depression and antidepressant use on goal setting and barrier identification in patients with type 2 diabetes.
Methods
In a large diabetes education network, 778 patients with type 2 diabetes were enrolled in the American Association of Diabetes Educators (AADE) Outcomes System as part of their routine diabetes education between 2005 and 2008. Self-reported depression, 7 self-identified behavior change goals, and 13 barriers to diabetes self-care were collected from the Diabetes Self-Management Assessment Report Tool (D-SMART ® ); antidepressant use was documented from the Diabetes Educator Tool (D-ET ® ). Multiple linear regression was used to evaluate the effects of depression or antidepressant use on the number of goals or the number of barriers while controlling for relevant covariates.
Results
Among 778 patients (507 nondepressed, 181 depressed with antidepressant use, 90 depressed without antidepressant use), median age was 58, 60.9% were female, and 85.9% were Caucasian. Patients with and without depression had a similar number of self-identified behavior change goals, whereas patients with depression had 1 additional barrier to diabetes self-care compared with those without depression. In the depressed subgroup, antidepressant use had no association with the number of goals that the subjects set or the number of barriers they identified.
Conclusions
Among patients with type 2 diabetes, depression was associated with a slightly greater number of barriers, which may support the importance of depression screening and depression treatment in patients with diabetes. D iabetes was the seventh leading cause of death reported on US death certificates in 2006. 1 The US Centers for Disease Control and Prevention (CDC) estimates that 7.8% of the US population (nearly 23.6 million people) suffer from diabetes. 1 Depression is a common comorbidity in people with diabetes mellitus. 2 The risk of depression is 50% to 100% higher in people with diabetes compared with the general population. 3 Diabetes self-care behaviors play a vital role in achieving optimal glycemic control, retarding the progression of complications, and decreasing morbidity and mortality associated with diabetes. [4] [5] [6] [7] Defined by American Association of Diabetes Educators (AADE), self-care behaviors are eating a healthful diet, being active, monitoring blood glucose, taking medication, solving problems, undertaking risk reduction activities, and healthy coping. They are known as AADE7 Self-Care Behaviors. 8 To improve diabetes self-care behaviors, the strategies of goal setting and barrier identification are widely used to assist people in making behavior change. [9] [10] [11] Goal setting is a collaborative process in which the patient is an active participant in deciding his or her own diabetes regimens. 10 This method may help people to improve recall of daily demands of diabetes and motivate them to participate in diabetes self-care. People who participate in the goalsetting process are more likely to overcome potential barriers to self-care and to achieve favorable diabetes outcomes. 10, [12] [13] [14] [15] [16] Barrier identification can minimize adverse effects on adherence to self-care behaviors. 17 Most people with diabetes encounter barriers to self-care, and these barriers are a major challenge when patients deal with daily demands of diabetes. [18] [19] [20] Those with multiple barriers are likely to reduce adherence to diabetes self-care. 21, 22 For people with diabetes, depression is associated with poor adherence to diabetes self-care, including an unhealthy diet [23] [24] [25] [26] [27] and low medication adherence. 23, [25] [26] [27] [28] [29] Four studies [30] [31] [32] [33] investigated the effects of depression treatment (antidepressants, behavioral therapies, or both) on diabetes self-care and found an inconsistent association between treatment of depression and diabetes selfcare. There was only 1 study evaluating the sole effects of antidepressants without combining other behavioral therapies, and it showed no difference on compliance with glucose monitoring and with medication regimen between people treated with nortriptyline and placebo. 31 Although a number of studies [23] [24] [25] [26] [27] [28] [29] investigated the association between depression and diabetes self-care behaviors, there is no literature addressing the effects of depression on goal setting and barrier identification in people with diabetes. Moreover, whether goal setting and barrier identification are improved by the use of antidepressants to alleviate depression is still unanswered.
Therefore, our first study aim was to evaluate the effects of depression on the number of self-identified behavior change goals and the number of barriers to diabetes self-care among patients with type 2 diabetes. Our second aim was to study the treatment effects of antidepressants on the number of self-identified behavior change goals and the number of barriers to diabetes selfcare in a subgroup with depression.
Methods

Study Setting
This analysis was conducted using data from AADE Outcomes System, which was developed to facilitate the delivery, documentation, and evaluation of patient behavior change in the provision of diabetes self-management education (DSME). 8 The AADE Outcomes System was integrated into Internet, touch-screen, and telephonic systems within 8 sites in the Pittsburgh Regional Initiative for Diabetes Education (PRIDE) network. 9 PRIDE is a regional health care collaboration established by the University of Pittsburgh Diabetes Institute to improve diabetes education and care in western Pennsylvania. 34 Patients with type 1 or type 2 diabetes were enrolled in the system as part of their routine diabetes education visits between 2005 and 2008. To be eligible for this study, complete data in the following fields were needed: self-reported depression, medications, self-identified behavior change goals, and barriers to diabetes self-care. Only patients with type 2 diabetes were included. The Figure 1 ). This study was approved by the Institutional Review Boards of the University of Pittsburgh.
Measurement
Two instruments were developed to collect data from patients (the Diabetes Self-Management Assessment Report Tool, D-SMART ® ) and from diabetes educators (the Diabetes Educator Tool, D-ET ® ). 9 The D-SMART is a self-reported instrument that gathers information about (1) demographics and health history and (2) behaviors and behavior change goals, organized in terms of the domains of the AADE7 Self-Care Behaviors. 9 Patients were asked to complete a baseline D-SMART prior to the start of DSME program. The D-ET was completed by the diabetes educator during the provision of DSME and provided an opportunity for the educator to record medical information about the patient and the educator's assessment of the patient's needs and progress. In the present study, self-reported depression, 7 self-identified behavior change goals, and 13 barriers to diabetes selfcare were collected from the D-SMART; antidepressant use was documented from the D-ET. Demographic and clinical data were obtained from either the D-SMART or the D-ET. Depression status was identified if patients reported "depression or anxiety" on the D-SMART or had records of antidepressant use according to the D-ET. 27 To determine self-identified behavior change goals, patients chose the domains in which they would like to make changes, including activity, eating, taking medication, monitoring, problem solving for blood sugars and sick days, reducing risks of diabetes complications, and living with diabetes. Patients also identified the level of each barrier that kept them from making the change. Among the 4 levels of each barrier to self-care, patients answering "a lot," "some," or "a little" were categorized as those who had barriers; patients answering "not at all" were categorized as those who did not have barriers.
Statistical Analysis
Demographic and clinical data were reported using measures of central tendency (percentage or mean/ medium). Comparisons between patients with and without depression or with and without antidepressant use were performed using the χ 2 test for categorical variables. Continuous variables were analyzed using the Student's t test or Wilcoxon rank sum test.
To test whether there is a difference in the number of self-identified behavior change goals and the number of barriers to diabetes self-care among those with or without depression as well as antidepressant use, linear regression was used. Normal modeling techniques were used. Those covariates whose P values were <.10 were considered for multivariable models except for age, which was forced into all models. Covariates for consideration included depression status (Y/N), antidepressant use (Y/N), baseline age (continuous), gender, race (Caucasian/non-Caucasian), education status (did not finish high school/high school/some college or greater), body mass index (BMI) (continuous), smoking (never/ former/current), alcohol drinking (Y/N), family history of diabetes (Y/N), diabetes duration (continuous), diabetes education (Y/N), the number of diabetes complications (continuous), A1C level (continuous), insulin use (Y/N), and the number of barriers (continuous). Transformation of covariates was performed where necessary. P values <.05 were considered significant. All analysis was completed using SAS 9.2. (SAS Institute, Cary, NC).
Results
Upon examination of those excluded from this analysis, we found that patients included were more likely to be Caucasian with higher BMI, less alcohol consumption, longer duration of diabetes, and more diabetes complications. They were also more likely to have family history of diabetes and insulin prescriptions. There was no difference between patients included and excluded in depression status, age, gender, education status, smoking, diabetes education, and A1C level (data not shown).
Among 778 patients included in this study, 507 (65.2%) patients were nondepressed and 271 (34.8%) were depressed (including 181 patients with antidepressant use and 90 patients without antidepressant use). Demographic and clinical characteristics of patients by depression/antidepressant status are shown in Table 1 .
Comparing patients with and without depression, depressed patients were younger (56 vs 60 years, P < .001), obese (34.4 vs 33.2 kg/m 2 , P = .03), female (72.0% vs 55.0%, P < .001), and currently smoking (28.5% vs 18.3%, P = .01). They were more likely to have 3 or more complications (45.4% vs 31.6, P < .001), kidney or bladder problems (22.5% vs 15.0%, P = .009), numbness or pain (50.9% vs 39.5%, P = .002), and vision problems (44.3% vs 30.6%, P < .001), whereas they were less likely to drink alcohol (20.4% vs 26.6%, P = .05). In the depressed subgroup, those treated with antidepressants were younger (55 vs 57 years, P = .04) and were more likely to have diabetes education (29.4% vs 14.4%, P = .007) than those not treated with antidepressants.
Self-Identified Behavior Change Goals
Unadjusted self-identified behavior change goals by depression/antidepressant status are presented in Table 2 . There was no difference in the number of goals between those with and without depression (2 vs 2, P = .11) or between those with and without antidepressant use in the depressed subgroup (2 vs 2, P = .26). Among 7 goals, the The P value is used to make comparisons between patients with and without antidepressant use in the depressed subgroup (column B vs column C). For categorical variables, the P value is generated from the χ 2 test. For continuous variables, the P value is generated from the Wilcoxon rank sum test because all the variables are not normally distributed.
depressed patients were more likely to choose "problem solving for blood sugars and sick days" as their goals compared with the nondepressed patients (21.8% vs 16.0%, P = .05). After adjustment for age, race, education, and the number of barriers, multivariable modeling showed that depression status had no association with the number of self-identified behavior change goals (P = .65) ( Table 3) . Younger age, Caucasian race, higher education, and a greater number of barriers were related to a greater number of goals. Similarly, there was no association between antidepressant use and the number of goals in the depressed subgroup while controlling for age and race (P = .36) ( Table 3 ).
Barriers to Diabetes Self-Care
Unadjusted barriers to diabetes self-care by depression/antidepressant status are presented in Table 4 . The most common barrier across all groups was "I don't know what to do or how to do it." Nine of 13 barriers were more frequently identified in the depressed patients compared with the nondepressed patients, such as "My health is not good" and "I don't have the will power." The number of barriers was greater in the depressed patients relative to the nondepressed patients (7 vs 6, P < .001). However, there was no difference in the number of barriers between those treated and not treated with antidepressants in the depressed subgroup (7 vs 7, P = .75).
After adjustment for age, BMI, race, education, and insulin use, the number of barriers to diabetes self-care remained greater in the depressed patients compared with the nondepressed patients (P < .001) ( Table 5 ). Higher BMI, non-Caucasian race, lower education, and insulin use were related to a greater number of barriers. However, antidepressant use had no association with the number of barriers while controlling for age, BMI, education, and insulin use (P = .99) ( Table 5 ). 
Discussion
In patients with type 2 diabetes enrolled in the AADE Outcomes System as part of their routine diabetes education, those with and without depression had a similar number of self-identified behavior change goals, whereas patients with depression had 1 additional barrier to diabetes self-care compared with those without depression. In the depressed subgroup, antidepressant use had no association with the number of goals they set or the number of barriers they identified.
Goal setting and barrier identification play important roles in helping patients make behavior change and achieving better diabetes self-care. Depression is not only a common comorbidity in patients with diabetes but also a well-known barrier that affects diabetes self-care.
Although several studies show negative effects of depression on diabetes self-care, [23] [24] [25] [26] [27] [28] [29] whether depression has influences on goal setting and barrier identification has not been well studied. The available study investigated only the effects of depression on goal achievement for clinical outcomes 35 rather than on goal setting for diabetes self-care. A number of studies explored barriers in patients with diabetes 22, [36] [37] [38] [39] rather than evaluated the effects of depression on patients' barriers to diabetes selfcare. Thus, our study is unique and provides important information for diabetes educators to help patients with diabetes and depression to set goals and identify barriers.
Beyond our expectation that patients with depression have decreased interest in making behavior change because of associated characteristics (such as pessimism and fatigue 40 ), we found that there was no association between depression and the number of self-identified behavior change goals. One possible explanation is that patients in our study were those who received routine diabetes education, and therefore they were more likely to pursue intensive treatments to achieve better diabetes outcomes. This impetus to seek help to improve their disease may compromise their negative behavioral style, leading to the absence of an effect of depression on goal setting.
Our study showed that patients with depression on average had 1 more barrier to diabetes self-care than those without depression. However, there was no difference between those with and without antidepressant use in the depressed subgroup. This result is similar to previous findings that the treatment of depression (antidepressants and/or behavioral therapies) had no effect on diabetes self-care behaviors (specifically, nutritional recommendations, smoking cessation, and foot care). [30] [31] [32] [33] Thus, these findings suggest that the treatment of depression alone may not be enough to address patients' barriers in order for them to achieve better diabetes self-care. Overcoming patients' barriers to diabetes self-care will require intensive interventions specific to each barrier. Another possibility is that complex diabetes regimens may reduce patients' adherence to antidepressants, [41] [42] [43] leading to equal performance regardless of antidepressant use. Based on our findings, patients with depression had about 1 barrier greater than those without depression. Although this difference between those with and without depression in the number of barriers is small, whether it can significantly influence diabetes self-care is unanswered. It is possible that depressed patients are likely to have certain barriers to diabetes self-care and therefore are likely to have poor adherence to the related domains of diabetes self-care. Thus, in future studies, it will be necessary to examine the effects of depression on each barrier and to evaluate the clinical significance of these effects on diabetes self-care. Goal setting, skill acquisition, and maintenance of motivation are important components for people with diabetes to achieve successful self-care, 44, 45 whereas depression is related to poor diabetes self-care. [23] [24] [25] [26] [27] [28] [29] In our study, we found that patients with and without depression were similar in the number of goals they set. Whether depression has effects on the setting of each goal is not well studied. If patients with and without depression do perform similarly in goal setting (ie, each goal and the sum of goals), this suggests that depressed patients may have some problems with skill acquisition or maintenance of motivation, which are also important components for self-care, so that they are less likely to have better diabetes self-care. Accordingly, exploring the factors that affect depressed patients in skill acquisition and maintenance of motivation is important in future studies.
Limitations
Our study had limitations that warrant consideration. First, to identify those with depression, we relied on patients' self-report in D-SMART and their records of antidepressant use in D-ET. Because some patients may not reveal their depression and not all depressed patients need to take antidepressants, the identification of depression on the basis of self-report and antidepressant use may underestimate the number of patients with depression. This misclassification bias may account for inability to detect significant differences. To avoid this bias, structured interviews are preferred in future studies to make a diagnosis of major depression. In addition, formal psychiatric assessment is considered to be the gold standard in identifying depressed patients. 29 Second, the goal setting and barrier identification were determined by patients using the D-SMART. Because there were 7 domains in goal setting and 13 items in barrier identification, some patients may feel burdened by completing all of the questions and may not answer all questions for goal setting and barrier identification. Thus, among 1575 patients with type 2 diabetes in this system, 442 (28.06%) patients had missing data in goal setting and 428 (27.17%) in barrier identification. Furthermore, those who were excluded from this study because of missing values were different from those who were included in some demographic and clinical characteristics (such as race, BMI, alcohol drinking, family history of diabetes, insulin use, diabetes duration, and complications), which may restrict the generalizability of the results. Third, this study was cross-sectional, and therefore temporality and causation cannot be established. For example, we were unable to determine whether depression increased the number of barriers to diabetes self-care, whether a greater number of barriers to diabetes self-care made patients feel depressed, or both. Thus, future longitudinal studies are needed to examine the cause-effect relationships. Fourth, the record of antidepressant use was obtained from the diabetes educator during the provision of DSME. However, the medication data indicated only medicines the patient was prescribed, not medicines they actually took. Thus, objective measurement (eg, electronic monitoring caps 29 ) may be needed to monitor medication adherence in future studies. Fifth, some antidepressants are used to treat not only depression but also other disorders. For example, duloxetine, a selective serotonin and norepinephrine reuptake inhibitor, is used as an antidepressant but also is widely used to inhibit pain caused by diabetic peripheral neuropathy. In our study, only 13 (2%) patients had records of duloxetine, and therefore this was not likely to affect our results.
Implications for Diabetes Educators
Depression is a common comorbidity and a barrier to diabetes self-care in people with diabetes. 36 In our study, depression was related to a greater number of barriers to diabetes self-care, which may indicate the importance of depression screening and treatment in patients with diabetes. Diabetes educators can play a key role in screening for depression. Although we found that antidepressant use had no association with the number of goals or the number of barriers, this does not imply that antidepressants are not useful in patients with diabetes and depression. Previous randomized controlled trial showed a significant improvement in depression for those receiving antidepressants. 31 In addition, intensive interventions combined with behavioral therapies may be necessary to help patients overcome their barriers. In summary, if depressed patients can be identified in the early stages of depression, diabetes educators can identify appropriate interventions earlier to help patients overcome potential barriers and achieve better diabetes self-care.
